These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 814373)

  • 1. [5-Nok in the treatment of candidiasis].
    Ljubojević S; Perinović M; Kesić V
    Med Arh; 1975; 29(6):643-4. PubMed ID: 814373
    [No Abstract]   [Full Text] [Related]  

  • 2. [8-hydroxyquinoline derivatives as wide-spectrum chemotherapeutic agents].
    Chernomordik AB
    Klin Med (Mosk); 1984 Feb; 62(2):133-6. PubMed ID: 6423880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with the preparation 5-NOK in a clinical trial. I. Microbiological investigation (author's transl].
    Hausnerová S; Tesarová Z; Uhlír O
    Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):97-101. PubMed ID: 124227
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new antifungal agent based on hydroxyquinoline].
    Knapp A; Haufe U; Haufe F; Schwenke W
    Dermatol Monatsschr; 1977 Jun; 163(6):471-7. PubMed ID: 409624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic experience with 5-chloro-8-hydroxyquinoline].
    Gärtner R; Kaben U
    Dermatol Monatsschr; 1977 Sep; 163(9):711-4. PubMed ID: 411692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [8-Hydroxyquinoline derivatives in the treatment of patients with onychomycoses].
    Butareva TA; Kukushkin AM; Unzhakov VP; Nemkaeva RM
    Vestn Dermatol Venerol; 1986; (12):50-3. PubMed ID: 2951932
    [No Abstract]   [Full Text] [Related]  

  • 7. [1st experiences with 5-nitro-oxyquinoline in the treatment of chronic urinary tract infection].
    Schlesinger E; Patsch R; Kraft M
    Z Urol Nephrol; 1975 Jun; 70(6):429-34. PubMed ID: 810992
    [No Abstract]   [Full Text] [Related]  

  • 8. Results obtained in Intestopan treatment of patients with dysenteric syndrome (adult patients).
    Münnich D; Bakondi M
    Ther Hung; 1975; 23(2):77-80. PubMed ID: 810910
    [No Abstract]   [Full Text] [Related]  

  • 9. The halogenated 8-hydroxyquinolines.
    Neldner KH
    Int J Dermatol; 1977 May; 16(4):267-73. PubMed ID: 140848
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chinosol as an anticandidal agent].
    Chernomordik AB; Gorshevikova EV
    Mikrobiol Zh (1978); 1988; 50(1):92-3. PubMed ID: 3150508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of skin tissue losses of different etiologies with 8-oxyquinoline associated with local anesthetics].
    Passarino M; Bogetti P; Lo Presti F; Perla A; Casale A; Giachero E; Anfossi G
    Minerva Chir; 1983 Jul 15-31; 38(13-14):1113-9. PubMed ID: 6415546
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indices for the user of halogenized 8-hydroxyquinolines in dermatology].
    Levkov AA; Dubiaga AN
    Vestn Dermatol Venerol; 1977 Feb; (2):69-72. PubMed ID: 404774
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of intestopan and other etiotropic agents in acute dysentery].
    Chaĭtsev VG; Chechel'nitskiĭ VM; Terent'ev VF
    Sov Med; 1977 Nov; (11):149-51. PubMed ID: 415374
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience in using new drug preparations for treating adult patients with acute intestinal infections].
    Mashilov VP; Avdeeva LA; Kaluzhina TI; Brodov LE; Golokhvastova EL; Iakovleva ON; Alikeeva GK
    Ter Arkh; 1990; 62(1):89-92. PubMed ID: 2110389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Remote results of treatment of patients with contagious forms of syphilis according to schedules of continuous treatment].
    Frishman MP; Nakonechnaia ZS; Dunaeva GA; Nikol'skaia EP; Tatskaia LS
    Vestn Dermatol Venerol; 1976 May; (5):45-8. PubMed ID: 823733
    [No Abstract]   [Full Text] [Related]  

  • 16. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
    Sturtevant FM
    Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Procedure for the preparation of effervescent vaginal tablets for veterinary use].
    Kovács I
    Acta Pharm Hung; 1975 Jul; 45(4):160-6. PubMed ID: 807083
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of enteroseptal and its analogs].
    Smirnov AN
    Feldsher Akush; 1977 Sep; 42(9):39-40. PubMed ID: 145967
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for treatment of candidiasis.
    Pappas PG; Rex JH; Sobel JD; Filler SG; Dismukes WE; Walsh TJ; Edwards JE;
    Clin Infect Dis; 2004 Jan; 38(2):161-89. PubMed ID: 14699449
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of oral candidiasis].
    Bánóczy J; Dombi C
    Orv Hetil; 2003 Oct; 144(42):2081-2. PubMed ID: 14658421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.